Trenaxa 250 coated tablets 250 mg. №12


Manufacturer: India



Bleeding or bleeding risk with increased fibrinolysis as generalized (bleeding during surgery and postoperative prostate, hemorrhagic complications of fibrinolytic therapy) and local (uterine, gastrointestinal, nasal bleeding, post-operative bleeding, post-operative bleeding) bladder, tonsillectomy, cervical conization, tooth extraction in hemophilia patients). Hereditary angioneurotic edema.